DGS Capital Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Sell
16,527
-433
-3% -$6.53K 0.04% 509
2025
Q4
$306K Buy
16,960
+110
+0.7% +$1.98K 0.05% 324
2025
Q3
$312K Sell
16,850
-216
-1% -$3.39K 0.06% 278
2025
Q2
$273K Buy
17,066
+267
+2% +$4.76K 0.06% 254
2025
Q1
$326K Hold
16,799
0.09% 213
2024
Q4
$370K Sell
16,799
-369
-2% -$7.1K 0.09% 189
2024
Q3
$289K Sell
17,168
-119
-0.7% -$1.77K 0.08% 222
2024
Q2
$207K Sell
17,287
-665
-4% -$7.43K 0.06% 261
2024
Q1
$199K Buy
17,952
+45
+0.3% +$459 0.06% 269
2023
Q4
$155K Sell
17,907
-8,708
-33% -$67.7K 0.06% 233
2023
Q3
$204K Sell
26,615
-818
-3% -$6.14K 0.1% 206
2023
Q2
$198K Buy
27,433
+1,862
+7% +$10.9K 0.1% 214
2023
Q1
$156K Buy
+25,571
New +$139K 0.09% 202
2022
Q3
Sell
-12,636
Closed -$64K 209
2022
Q2
$64K Buy
+12,636
New +$65.7K 0.05% 187

Other funds holding CLBT